NHF-15958-02286
2 vaccinations
2 coded responses
4 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 196 / PA
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2022-01-13
Dose 1 — Moderna
-
2022-02-10
Dose 2 — Moderna
-
2022-02-13
Survey response — days 1–6 daily, dose 2MedDRA: Vertigo — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Several VertigoMedDRA releases: 2024-11 · check-in free text available
-
2022-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitAdult check-in
-
2022-02-14
Report sent to call center — days 1–6 daily, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-21
- 2022-02-24
- 2022-03-17
-
2023-02-10
Survey response — 12 months, dose 2MedDRA: SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-02-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-02-13
- 2023-02-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-13 | Moderna | No |
| 2 | 2022-02-10 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 11 — days 1–6 daily, dose 2
Systemic reaction (other): Several Vertigo
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release